Notice of Changes to the Funding Opportunity Announcement PAR-15-327 "Ethical, Legal and Policy Issues in HIV Research with Key Populations (R21)"

Notice Number: NOT-AI-16-061

Key Dates
Release Date:  June 7, 2016

Related Announcements
PAR-15-327       

Issued by
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Mental Health (NIMH)

Purpose

The purpose of this Notice is to provide three modifications to the funding opportunity announcement (FOA) PAR-15-327  titled, "Ethical, Legal and Policy Issues in HIV Research with Key Populations (R21)".

Modification 1:  Cancellation of one Application Due Date for PAR-15-327.  Effective immediately, the January 7, 2017 Application Due Date/AIDS Application Due Date is eliminated and Letters of Intent to submit an application are requested 30 days prior to the relevant application due date.

Part 1. Overview Information
Key Dates
Current Language:

Posted Date
June 9, 2015

Open Date (Earliest Submission Date)
December 7, 2015

Letter of Intent Due Date(s)
Not Applicable

Application Due Date(s) 
January 7, 2016; September 7, 2016; January 7, 2017; September 7, 2017; January 8, 2018; September 7, 2018 by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)
January 7, 2016; September 7, 2016; January 7, 2017; September 7, 2017; January 8, 2018; September 7, 2018 by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review
February 2016; October 2016; February 2017; October 2017; February 2018; October 2018

Advisory Council Review 
May 2016; January 2017; May 2017; January 2018; May 2018; January 2019

Earliest Start Date 
July 2016; April 2017; July 2017; April 2018; July 2018; April 2019

Expiration Date  
September 8, 2018

New Language:

Posted Date
June 9, 2015

Open Date (Earliest Submission Date) 
December 7, 2015

Letter of Intent Due Date(s) 
30 days before the application due date

Application Due Date(s)
January 7, 2016; September 7, 2016; September 7, 2017; January 8, 2018; September 7, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)
January 7, 2016; September 7, 2016; September 7, 2017; January 8, 2018; September 7, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review 
February 2016; October 2016; October, 2017; February 2018; October 2018  

Advisory Council Review
May 2016; January 2017; January 2018; May 2018; January 2019

Earliest Start Date 
July 2016; April 2017; April 2018; July 2018 ; April 2019

Expiration Date
September 8, 2018

Modification 2: The submission of letters of intent are requested for PAR-15-327.

Section IV. Application and Submission Information
2. Content and Form of Application Submission

Letter of Intent

Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.

By the date listed in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:

  • Descriptive title of proposed research
  • Name(s), address(es), and telephone number(s) of the PD(s)/PI(s)
  • Names of other key personnel
  • Participating institution(s)
  • Number and title of this funding opportunity

 
The letter of intent should be sent to:

Liza Dawson, Ph.D.
Team Leader, Research Ethics Team
Basic Sciences Program
Division of AIDS
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3210
Email: DawsonL@niaid.nih.gov

Modification 3:  NIAID reiterates the NIH overarching HIV/AIDS research priorities and guidelines for determining AIDS funding as noted in NIH Guide Notice NOT-OD-15-137 published on August 12, 2015.  Potential applicants are encouraged to review the description of these priority topics and examples that are provided in the Notice. We strongly advise applicants to focus their research projects on high-priority topics only. This FOA will not support low-priority topics.

All other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to:

Liza Dawson, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3210
Email: DawsonL@niaid.nih.gov